Search research articles
Contact Us
Filters
Showing results (91-100 of 133) with videos related to
Page
of 14
Sort By:
Hemasphere
|
June 19, 2026
Phase 3 PERSPECTIVE study: Ibrutinib with rituximab for initial treatment of patients with follicular lymphoma
David Belada, Faithlore P Gardner, Ana C de Oliveira, et al.
Blood
|
March 2, 2026
Fixed-duration VenO vs FCR/BR in fit patients with untreated CLL: primary analysis of the phase 3 CRISTALLO trial
Jeff P Sharman, Luca Laurenti, Emmanuelle France Ferrant, et al.
Blood
|
January 3, 2012
Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma
Robert Kridel, Barbara Meissner, Sanja Rogic, et al.
Internal Medicine Journal
|
March 7, 2025
Ratifying the efficacy and safety of intensive induction chemotherapy for acute myeloid leukaemia by the Australasian Leukaemia & Lymphoma Group consensus approach
Aditya Tedjaseputra, Amanda Tey, Anastasios Nalpantidis, et al.
Cancers
|
June 10, 2022
Associations between Smoking and Alcohol and Follicular Lymphoma Incidence and Survival: A Family-Based Case-Control Study in Australia
Michael K Odutola, Marina T van Leeuwen, Jennifer Turner, et al.
Advances in Therapy
|
July 28, 2022
Zanubrutinib Monotherapy for Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Pooled Analysis of Three Studies
Wei Xu, Shenmiao Yang, Constantine S Tam, et al.
Blood
|
July 26, 2019
Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL
Constantine S Tam, Judith Trotman, Stephen Opat, et al.
Journal of Hematology & Oncology
|
October 15, 2021
Zanubrutinib monotherapy in relapsed/refractory mantle cell lymphoma: a pooled analysis of two clinical trials
Keshu Zhou, Dehui Zou, Jianfeng Zhou, et al.
Cancer Medicine
|
September 14, 2023
Long-term outcomes of second-line versus later-line zanubrutinib treatment in patients with relapsed/refractory mantle cell lymphoma: An updated pooled analysis
Yuqin Song, Keshu Zhou, Dehui Zou, et al.
Cancer Epidemiology
|
September 4, 2022
Associations between early-life growth pattern and body size and follicular lymphoma risk and survival: a family-based case-control study
Michael K Odutola, Marina T van Leeuwen, Jennifer Turner, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 133) with videos related to
Sort By:
Page
of 14
Hemasphere
|
June 19, 2026
Phase 3 PERSPECTIVE study: Ibrutinib with rituximab for initial treatment of patients with follicular lymphoma
David Belada, Faithlore P Gardner, Ana C de Oliveira, et al.
Blood
|
March 2, 2026
Fixed-duration VenO vs FCR/BR in fit patients with untreated CLL: primary analysis of the phase 3 CRISTALLO trial
Jeff P Sharman, Luca Laurenti, Emmanuelle France Ferrant, et al.
Blood
|
January 3, 2012
Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma
Robert Kridel, Barbara Meissner, Sanja Rogic, et al.
Internal Medicine Journal
|
March 7, 2025
Ratifying the efficacy and safety of intensive induction chemotherapy for acute myeloid leukaemia by the Australasian Leukaemia & Lymphoma Group consensus approach
Aditya Tedjaseputra, Amanda Tey, Anastasios Nalpantidis, et al.
Cancers
|
June 10, 2022
Associations between Smoking and Alcohol and Follicular Lymphoma Incidence and Survival: A Family-Based Case-Control Study in Australia
Michael K Odutola, Marina T van Leeuwen, Jennifer Turner, et al.
Advances in Therapy
|
July 28, 2022
Zanubrutinib Monotherapy for Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Pooled Analysis of Three Studies
Wei Xu, Shenmiao Yang, Constantine S Tam, et al.
Blood
|
July 26, 2019
Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL
Constantine S Tam, Judith Trotman, Stephen Opat, et al.
Journal of Hematology & Oncology
|
October 15, 2021
Zanubrutinib monotherapy in relapsed/refractory mantle cell lymphoma: a pooled analysis of two clinical trials
Keshu Zhou, Dehui Zou, Jianfeng Zhou, et al.
Cancer Medicine
|
September 14, 2023
Long-term outcomes of second-line versus later-line zanubrutinib treatment in patients with relapsed/refractory mantle cell lymphoma: An updated pooled analysis
Yuqin Song, Keshu Zhou, Dehui Zou, et al.
Cancer Epidemiology
|
September 4, 2022
Associations between early-life growth pattern and body size and follicular lymphoma risk and survival: a family-based case-control study
Michael K Odutola, Marina T van Leeuwen, Jennifer Turner, et al.
Page
of 14